Sachs Center Launches Free AI Tool Empowering Neurodivergent Adults to Decode Everyday Communication
Sachs Center is proud to announce the launch of its groundbreaking AI tool, designed specifically to support neurodivergent adults.NEW YORK,...
Day: August 28, 2024
Rutherrin(R) Increases Efficacy of Chemotherapy for Lung Cancer
TORONTO, ON / ACCESSWIRE / August 28, 2024 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage...
Correction: Cantargia Publishes Half-Year Report 2024
Correction of sign on three values in the Changes in working capital on page 16 of the report. Corrected values...
Sonoma Pharmaceuticals Announces 1-for-20 Reverse Split of Outstanding Common Stock
BOULDER, CO / ACCESSWIRE / August 28, 2024 / Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global healthcare leader developing and producing...
HOOKIPA Pharma to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
NEW YORK and VIENNA, Aug. 28, 2024 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, “HOOKIPA”, the “Company”), a company...
SciSparc Grants Global Rights for Pain Therapy to Biotech Company in Agreement Worth up to $6 Million
SciSparc would be entitled to receive consideration valued at $3 million in Polyrizon securities, as well as potential milestone fees...
Kane Biotech Announces Distribution Agreement with Qatar Datamation Systems for revyve™ Antimicrobial Wound Gel
Company’s Second Distribution Agreement in Middle EastWINNIPEG, Manitoba, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF)...
Sienna Senior Living Announces Closing of Common Share Offering for Gross Proceeds of Approximately $144 Million
NOT FOR DISTRIBUTION TO THE U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATESMARKHAM, Ontario, Aug. 28, 2024 (GLOBE...
NurExone Reports Second Quarter 2024 Financial Results and Provides Corporate Update
TORONTO and HAIFA, Israel, Aug. 28, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (Germany: J90) (the...
Aprea Therapeutics to Present at the H.C. Wainwright Annual Global Investment Conference
DOYLESTOWN, Pa., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea” or the “Company”), a clinical stage...
Ascendis Pharma to Report Second Quarter 2024 Financial Results and Provide Business Update on September 3, 2024
COPENHAGEN, Denmark, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced it will report second quarter...
IMUNON to Host R&D Day on September 18th
R&D Discussion in New York City to Review IL-12’s Potential to Treat Ovarian Cancer Program Features Ovarian Cancer Thought Leaders,...
Mestag Therapeutics Awarded Significant Grant from Innovate UK’s Prestigious Cancer Therapeutics Program to Accelerate the Path to the Clinic for MST-0300
Mestag Therapeutics Employees of Cambridge, UK based Mestag Therapeutics - Innovate UK, part of UK Research and Innovation, is investing...
Intra-Cellular Therapies to Present at Three Upcoming Investor Conferences
NEW YORK, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development...
Alignment Healthcare to Present at Baird Global Healthcare Conference
ORANGE, Calif., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), today announced that John Kao, founder and...
Awakn Announces Key Progress in Its Aminoindane Pre-Clinical Program
Toronto, Ontario--(Newsfile Corp. - August 28, 2024) - Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF), a clinical-stage biotechnology company...
Optimi Health & ATMA Receive No Objection Letter from Health Canada for Phase 2 Clinical Trial
Trial to study Major Depressive Disorder using Optimi's GMP natural psilocybin capsules in conjunction with therapyVancouver, British Columbia--(Newsfile Corp. -...
Tribun Health Partners With Ibex to Deliver Advanced AI Diagnostic Solutions
ARIS, FRANCE AND MONTREAL, QUEBEC / ACCESSWIRE / August 28, 2024 / Tribun Health, a leading provider of digital pathology...
Occlutech(R) Announces Commercial Cases of Occlutech ASD Occluder Device Implantation in the U.S.
SCHAFFHAUSEN, CH / ACCESSWIRE / August 28, 2024 / Occlutech Holding AGProcedures carried out at a number of leading cardiac...
Cantargia Publishes Half-Year Report 2024
LUND, SE / ACCESSWIRE / August 28, 2024 / Cantargia (STO:CANTA) Cantargia (Cantargia AB (publ); Nasdaq Stockholm:CANTA) today announced its...